Phenotypic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127low Treg Cells in Patients with Chronic Rheumatoid Arthritis

Arthritis and Rheumatology

Volumn 68, Issue 1, 2016, Pages 103-116

  Walter, Gina J ^a,d   Fleskens, Veerle ^a   Frederiksen, Klaus S ^b   Rajasekhar, Megha ^a   Menon, Bina ^c   Gerwien, Jens G ^b   Evans, Hayley G ^a,e   Taams, Leonie S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NOVO NORDISK A S   (Denmark)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CD161 ANTIGEN; CD3 ANTIGEN; CD39 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOKINE; RANTES; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR; CD45 ANTIGEN; CYTOKINE; IL10 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 7 RECEPTOR ALPHA; TNF PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL COMPARTMENTALIZATION; CELL FUNCTION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; ADOLESCENT; CASE CONTROL STUDY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD4; ANTIGENS, CD45; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84951971547     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39408     Document Type: Article

References (51)

1. brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003; 33: 215-23.
2. Van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS., CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004; 50: 2775-85.
3. Liu MF, Wang CR, Fung LL, Lin LH, Tsai CN., The presence of cytokine-suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand J Immunol 2005; 62: 312-7.
4. Mottonen M, Heikkinen J, Mustonen L, Isomaki P, Luukkainen R, Lassila O., CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005; 140: 360-7.
5. high regulatory T cell population in peripheral blood. Rheumatology (Oxford) 2006; 45: 1210-7.
6. Jiao Z, Wang W, Jia R, Li J, You H, Chen L, et al., Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis. Scand J Rheumatol 2007; 36: 428-33.
7. Benito-Miguel M, Garcia-Carmona Y, Balsa A, Perez de Ayala C, Cobo-Ibanez T, Martin-Mola E, et al., A dual action of rheumatoid arthritis synovial fibroblast IL-15 expression on the equilibrium between CD4+CD25+ regulatory T cells and CD4+CD25- responder T cells. J Immunol 2009; 183: 8268-79.
8. low regulatory T cells. Arthritis Rheum 2013; 65: 627-38.
9. Morgan ME, Sutmuller RP, Witteveen HJ, van Duivenvoorde LM, Zanelli E, Melief CJ, et al., CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 2003; 48: 1452-60.
10. Frey O, Petrow P, Gajda M, Siegmund K, Huehn J, Scheffold A, et al., The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 2005; 7: R291-301.
11. Morgan M, Flierman R, van Duivenvoorde L, Witteveen HJ, van Ewijk W, van Laar JM, et al., Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005; 52: 2212-21.
12. Nguyen LT, Jacobs J, Mathis D, Benoist C., Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 2007; 56: 509-20.
13. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al., Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med 2004; 200: 277-85.
14. Nie H, Zheng Y, Li R, Guo TB, He D, Fang L, et al., Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat Med 2013; 19: 322-8.
15. hi T regulatory cells. Blood 2006; 108: 253-61.
16. Zanin-Zhorov A, Ding Y, Kumari S, Attur M, Hippen KL, Brown M, et al., Protein kinase C-θ mediates negative feedback on regulatory T cell function [published erratum appears in Science 2010;328:974]. Science 2010; 328: 372-6.
17. Cribbs AP, Kennedy A, Penn H, Read JE, Amjadi P, Green P, et al., Treg cell function in rheumatoid arthritis is compromised by CTLA-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway. Arthritis Rheumatol 2014; 66: 2344-54.
18. McGovern JL, Nguyen DX, Notley CA, Mauri C, Isenberg DA, Ehrenstein MR., Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy. Arthritis Rheum 2012; 64: 3129-38.
19. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64.
20. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, et al., Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 162: 5317-26.
21. Powell BR, Buist NR, Stenzel P., An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 1982; 100: 731-7.
22. Wildin RS, Smyk-Pearson S, Filipovich AH., Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genetics 2002; 39: 537-45.
23. high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. Cell Immunol 2008; 253: 92-101.
24. Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, et al., Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006; 27: 110-8.
25. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004; 6: R335-46.
26. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004; 172: 6435-43.
27. + T cells in rheumatic joints. Scand J Immunol 2006; 63: 444-52.
28. Wehrens EJ, Mijnheer G, Duurland CL, Klein M, Meerding J, van Loosdregt J, et al., Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells. Blood 2011; 118: 3538-48.
29. Haufe S, Haug M, Schepp C, Kuemmerle-Deschner J, Hansmann S, Rieber N, et al., Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells. Arthritis Rheum 2011; 63: 3153-62.
30. Herrath J, Muller M, Amoudruz P, Janson P, Michaelsson J, Larsson PT, et al., The inflammatory milieu in the rheumatic joint reduces regulatory T cell function. Eur J Immunol 2011; 41: 2279-90.
31. Xiao H, Wang S, Miao R, Kan W., TRAIL is associated with impaired regulation of CD4+CD25- T cells by regulatory T cells in patients with rheumatoid arthritis. J Clin Immunol 2011: 31: 1112-9.
32. Michels-van Amelsfort JM, Walter GJ, Taams LS., CD4+CD25+ regulatory T cells in systemic sclerosis and other rheumatic diseases. Expert Rev Clin Immunol 2011; 7: 499-514.
33. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL., Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
34. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 1693-700.
35. Taams LS, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN., Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 2001; 31: 1122-31.
36. Pitzalis C, Kingsley G, Murphy J, Panayi G., Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol 1987; 45: 252-8.
37. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, et al., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257-65.
38. Afzali B, Mitchell PJ, Edozie FC, Povoleri GA, Dowson SE, Demandt L, et al., CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. Eur J Immunol 2013; 43: 2043-54.
39. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, et al., Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899-911.
40. low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J Immunol 2008; 180: 6411-20.
41. Haas J, Fritzsching B, Trubswetter P, Korporal M, Milkova L, Fritz B, et al., Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol 2007; 179: 1322-30.
42. Jana S, Campbell H, Woodliff J, Waukau J, Jailwala P, Ghorai J, et al., The type of responder T-cell has a significant impact in a human in vitro suppression assay. PloS One 2010; 5: e15154.
43. Tiemessen MM, Jagger AJ, Evans HG, van Herwijnen MJ, John S, Taams LS., CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A 2007; 104: 19446-51.
44. Sakaguchi S, Miyara M, Costantino CM, Hafler DA., FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10: 490-500.
45. Afzali B, Mitchell P, Lechler RI, John S, Lombardi G., Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol 2010; 159: 120-30.
46. Herrath J, Chemin K, Albrecht I, Catrina AI, Malmstrom V., Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion. Eur J Immunol 2014; 44: 2979-89.
47. Cribbs AP, Kennedy A, Penn H, Amjadi P, Green P, Read JE, et al., Methotrexate restores regulatory T cell function through demethylation of the FoxP3 upstream enhancer in patients with rheumatoid arthritis. Arthritis Rheumatol 2015; 67: 1182-92.
48. Peres RS, Liew FY, Talbot J, Carregaro V, Oliveira RD, Almeida SL, et al., Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis. Proc Natl Acad Sci U S A 2015; 112: 2509-14.
49. Monte K, Wilson C, Shih FF., Increased number and function of FoxP3 regulatory T cells during experimental arthritis. Arthritis Rheum 2008; 58: 3730-41.
50. Grinberg-Bleyer Y, Saadoun D, Baeyens A, Billiard F, Goldstein JD, Gregoire S, et al., Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J Clin Invest 2011; 120: 4558-68.
51. Van Loosdregt J, Fleskens V, Fu J, Brenkman AB, Bekker CP, Pals CE, et al., Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity. Immunity 2013; 39: 259-71.